MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$6,811K
Deferred offering costs
$634K
Prepaid expenses and
other current assets
$567K
Restricted cash
$94K
Total current assets
$8,106K
Total assets
$8,106K
Total liabilities and
stockholders equity...
$8,106K
Total stockholders
equity (deficit)
$5,787K
Total current
liabilities
$2,319K
Accumulated deficit
-$723,901K
Additional paid in capital
$729,661K
Accrued expenses
$1,560K
Accounts payable
$748K
Warrant liability
$11K
Common stock, par value
0.001, 250,000,000...
$26K
Preferred stock
value-Series CPreferred...
$1K
Back
Back
Balance Sheet
source: myfinsight.com
GT Biopharma, Inc. (GTBP)
GT Biopharma, Inc. (GTBP)